Resource Logo
Miscellaneous News

Starting HIV treatment with a CD4 cell count below 350 associated with a key marker of cardiovascular risk


Starting HIV treatment with a CD4 cell count below 350 cells/mm3 may increase the long-term risk of cardiovascular disease, US research published in AIDS suggests. Investigators found that men who started therapy with a CD4 cell count below this threshold had much poorer endothelial function, a key measure of vascular health, than individuals who started treatment when their CD4 cell count was above 350 cells/mm3.

Please click here for the full article.


Copyright © 2012 -Social Security Office, Publisher. All rights reserved to AIDS & Public PolicyJournal. Reproduction of this article (other than one copy for personal reference) must be cleared through the APPJ Permissions Desk.

Information in this article was accurate in May 25, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.